6533b7dbfe1ef96bd1270b15
RESEARCH PRODUCT
Telemedicine allows quantitative measuring of olfactory dysfunction in COVID‐19
Christoph MatthiasMagdalena SpielhaupterKarl HörmannJan HagemannSabine StielowLudger KlimekTilman HuppertzLaura FreudelspergerAli Alalisubject
AdultMaleTelemedicine2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCOVID-19VirologyTelemedicineOlfaction DisordersHumansMedicineImmunology and AllergyFemaleLetters to the EditorbusinessLetter to the Editoryear | journal | country | edition | language |
---|---|---|---|---|
2020-07-20 | Allergy |